Back

Phenogrouping HFpEF trajectories identifies early and end-stage subtypes: a multicentre study using natural language processing

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: HFpEF issues Heart Failure with Preserved Ejection Fraction (HFpEF) ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Sam Brown

King's College Hospital NHS Foundation Trust, London (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Insights into pulmonary remodelling in heart failure with preserved ejection fraction through transpulmonary biomarker gradients
Doctor M. Dagan (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Small left ventricle in patients with heart failure with preserved ejection fraction is associated with higher mortality
Doctor Y. Nakagawa (Kawanishi, JP)
Abstract Slides Video
Presentation thumbnail
Gender-specific outcomes and treatment responses in elderly HFpEF patients: a comprehensive single-center retrospective study
Doctor K. Shi (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Dapagliflozin versus empagliflozin in patients with heart failure with preserved ejection fraction
Doctor J. Kassab (Dallas, US)
Abstract Slides Video
Presentation thumbnail
Characteristics of pulmonary hypertension in adults with left ventricular diastolic dysfunction
Doctor S. Ratwatte (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
HFpEF issues

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Phenomapping of patients with acute heart failure with preserved ejection fraction using machine learning-based cluster analysis and long-term mortality in a real world cohort in Argentina
thumbnail
Congress Presentation
Real-world evidence for patient phenotypes in heart failure with preserved ejection fraction
thumbnail
Congress Presentation
Deep learning-based phenotyping and assessment of treatment responses in heart failure with preserved ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources